Mr. Durbin (for himself, Mr. Grassley, Mr. King, Ms. Ernst, Ms. Smith, Mr. Welch, Mr. Blumenthal, Ms. Baldwin, and Mr. Tuberville) introduced the following bill; which was read twice and referred to the Committee on Finance
To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.
Chuck Grassley
(IA); Angus S. King Jr.
(ME); Joni Ernst
(IA); Tina Smith
(MN); Peter Welch
(VT); Richard Blumenthal
(CT); Tammy Baldwin
(WI); Tommy Tuberville
(AL)
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Drug-price Transparency for Consumers Act of 2025. S. 229. 119th
Cong., 1st
sess., Introduced in Senate January 23, 2025. https://www.govinfo.gov/app/details/BILLS-119s229is.
APA
Congress, Senate (2025, January 23). Drug-price Transparency for Consumers Act of 2025 (S. 229 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s229is.
MLA
United States, Congress, Senate. Drug-price Transparency for Consumers Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s229is. 119th Congress, S. 229, Introduced in Senate 23 Jan. 2025.
Bluebook
S.229 - 119th Congress (2025-2026): Drug-price Transparency for Consumers Act of 2025, S.229, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s229is.
